With the BR2 nuclear reactor in Belgium back online, healthcare technology firm Covidien is predicting more reliable supplies of technetium-99m (Tc-99m) for the rest of June.
The Dublin, Ireland-based company's latest supply update noted that the BR2 reactor added an extra manufacturing cycle this month, after Covidien provided funding to support the added BR2 cycle.
Covidien also has been collaborating with the Institute for Radioelements (IRE) to validate molybdenum-99 from the Czech Rez reactor for use in Tc-99m generator production for European, U.S., and Canadian patient procedures.
Related Reading
Covidien to buy ev3 for $2.6B, June 1, 2010
Covidien updates May Mo-99 supply status, May 6, 2010
Covidien Mo-99 production resumes, April 27, 2010
Covidien pharma sales fall in Q2, April 21, 2010
Covidien warns of 'extreme' Mo-99 shortage in May, March 30, 2010
Copyright © 2010 AuntMinnie.com
